Product details:
ISBN13: | 9780323939478 |
ISBN10: | 0323939473 |
Binding: | Hardback |
No. of pages: | 240 pages |
Weight: | 450 g |
Language: | English |
642 |
Category:
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination., An Issue of Clinics in Liver Disease
Series:
The Clinics: Internal Medicine;
27-4;
Publisher: Elsevier
Date of Publication: 4 October 2023
Normal price:
Publisher's listprice:
EUR 86.99
EUR 86.99
Your price:
28 717 (27 350 HUF + 5% VAT )
discount is: 20% (approx 7 179 HUF off)
Discount is valid until: 30 June 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
printed on demand
Can't you provide more accurate information?
Long description:
In this issue of Clinics in Liver Disease, guest editor Robert G. Gish brings his considerable expertise to the topic of Hepatitis B and Hepatitis D. The articles provide state-of-the-art clinical summaries of the advances in Hepatitis B and D, with emphasis on HBV viro-immunology, novel assays, new targets, and tests for HBV and HDV, and more.
Table of Contents:
Chronic Hepatitis B: Treat all Who Are Viremic?
Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
What Is the Current Status of Hepatitis B Virus Viro-Immunology?
Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
Overview of New Targets for Hepatitis B Virus: Immune Modulators, Interferons, Bifunctional Peptides, Therapeutic Vaccines and Beyond
Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers
Targeting Hepatitis B Virus DNA Using Designer Gene Editors
Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus
State of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction Quantification
Triple Threat: HDV, HBV, HIV Coinfection
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?
What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options
Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible
Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
What Is the Current Status of Hepatitis B Virus Viro-Immunology?
Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
Overview of New Targets for Hepatitis B Virus: Immune Modulators, Interferons, Bifunctional Peptides, Therapeutic Vaccines and Beyond
Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers
Targeting Hepatitis B Virus DNA Using Designer Gene Editors
Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus
State of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction Quantification
Triple Threat: HDV, HBV, HIV Coinfection
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?
What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options
Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible